CU Heme Logo
Contact Us

Homepage

The

Robert H. Allen

Memorial

Hematology Symposia

The

Robert H. Allen

Memorial

Hematology Symposia

A series for continuing education - free to those who register.

Register Here

Join Us!

BROADCAST FROM DENVER, COLORADO | NEXT SESSION APRIL 18, 2024!

Dr. Robert Allen

Dr. Allen served as the Division of Hematology Chief for nearly 40 years at University of Colorado. He dedicated his life to educating the future generation of hematologists.

Dr. Allen served as the Division of Hematology Chief for nearly 40 years at University of Colorado. He dedicated his life to educating the future generation of hematologists.

MEET THE
Hematology Symposia
PRESENTERS

2023 - 2024

Ara Metjian, MD

Updates in
Immune Thrombotic
Thromobocytopenic Purpura
(iTTP): Challenges & Prospects
Register Here for April 18, 2024
April 18!

Jager Jasem, MD, MPH

July 20, 2023

Marc Schwartz, MD

October 19, 2023
MEET OUR ENTIRE TEAM >
ALL Division of Hematology
CE Events >

2023 - 2022
Hematology Symposia
PRESENTERS

March 16, 2023
Oncological Emergencies
in Acute
Myeloid Leukemia

Glen Peterson

DNP, ACNP, RN

February 16, 2023
Evaluation of Generalized
Joint Hypermobility
in Individuals with
Abnormal Bleeding

Genevieve Moyer

MD, MSC

December 15, 2022
Drug-Resistant
Subpopulations in Patients
with Multiple Myeloma

Dan Sherbenou

MD, PhD

November 17, 2022
Venetoclax and Transplant
in AML:
Oh, the Places You’ll Go!

Jonathan Gutman

MD

October 20, 2022
Guidelines-based
Management of Von
Willebrand Disease

Tyler Buckner

MD

September 15, 2022
Updates In
Therapeutics for
Sickle Cell

Gemlyn George

MD

July 21, 2022
Myeloid Malignancies
and
Novel Therapies

Dan Pollyea

MD, MS

June 16, 2022
A Personalized
Approach for
T-cell Lymphomas

Brad Haverkos

MD

April 21, 2022
Sexual Dysfunction
Following Stem Cell
Transplant

Rebecca Hunter

PhD

Previous
Next

Mantle Cell Lymphoma: Challenges & Prospects

***

Presentation Slides

Jager Jasem, MD, MPH

Management of Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia in the Era of Novel Immunotherapy: Case-based Discussion

***

Presentation Slides

Marc Schwartz, MD

Oncological Emergencies in Acute Myeloid Leukemia

This presentation will discuss the common oncological emergencies and complications associated with newly diagnosed or relapsed and/or refractory AML. This will include the diagnosis, prevention and acute management of AML complications.
Presentation Slides

Glen Peterson, DNP, ACNP, RN

Evaluation of Generalized Joint Hypermobility in Individuals with Abnormal Bleeding

This presentation will discuss the pathophysiology of connective tissue/collagen vascular disease as it relates to abnormal bleeding symptoms and review the screening tools that hematologists, primary care providers, and gynecologists should be aware. I will also discuss the hematologists’ role in managing patients with generalized joint hypermobility.
Presentation Slides

Genevieve Moyer, MD, MSC

Drug-Resistant Subpopulations in Patients with Multiple Myeloma

This presentation will discuss the treatment landscape for multiple myeloma, identify basic treatment sequencing in multiple myeloma and evaluate the potential roles of disease heterogeneity in disease response to treatment.  
Presentation Slides

Dan Sherbenou, MD, PhD

Venetoclax and Transplant in AML: Oh, the
Places You'll Go!

This presentation will review the potential of venetoclax to enable and improve stem cell transplantation and to alter the paradigm of AML treatment.
Presentation Slides

Jonathan Gutman, MD

Guidelines-based Management of Von Willebrand Disease

This presentation will provide health care professionals with tools to systematically assess and quantify patients’ bleeding symptoms.
Presentation Slides

Tyler Buckner, MD

Updates in Therapeutics for Sickle Cell

This presentation will discuss the inflammation pathway involved in the pathophysiology of sickle cell disease and the underlying drugs used to target the inflammation pathway.
Presentation Slides

Gemlyn George, MD

Myeloid Malignancies and Novel Therapies

This presentation will review recent developments in the field of MDS and AML, discuss many of the new therapies approved and some that were not, and discuss promising future strategies that may be approved in the near future.
Presentation Slides

Dan Pollyea, MD, MS

A Personalized Approach for T-cell Lymphomas

This presentation will review different clinical presentations and complications of TCLs, discuss different treatment options, and outcomes.
Presentation Slides

Brad Haverkos, MD

Sexual Dysfunction Following Stem Cell Transplant

This presentation will increase health care professionals’ knowledge about the prevalence of sexual dysfunction following stem cell transplant, contributors to sexual dysfunction, how and why these issues are often unaddressed, and assessment/intervention strategies to treat sexual dysfunction following transplant.
Presentation Slides

Rebecca Hunter, PhD